MedTrace Logo

One Month Dose Response Study of AZD1981 in Asthma Patients Uncontrolled on Inhaled Steroids

NCT00758589 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 368

Last updated 2014-02-26

Study results available
· View outcomes & findings →

Summary

The primary objective of this study is to evaluate efficacy of AZD1981 in uncontrolled asthmatic patients on maintenance inhaled glucocorticosteroids.

Conditions

Interventions

DRUG

AZD1981

Oral tablet, 50 mg twice daily

DRUG

AZD1981

Oral tablet, 400 mg twice daily

DRUG

AZD1981

Oral tablet, 1000 mg twice daily

DRUG

Placebo

Sponsors & Collaborators

Principal Investigators

  • Piotr Kuna · University of Lodz, Lodz, Poland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Completion
2009-07-31

Countries

  • Argentina
  • Brazil
  • Costa Rica
  • Poland

Study Locations

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00758589 on ClinicalTrials.gov